Top Markets
#1 SAFEcoin SAFEcoin +59.28%
#2 Zora Zora +29.49%
#3 AI XOVIA AI XOVIA +28.62%
#4 Full Moon Full Moon +19.62%
#5 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#6 0G 0G +14.98%
#7 Axelar Axelar +14.88%
#8 Bless Bless +13.79%
#9 VVS Finance VVS Finance +13.64%
#10 Apertum Apertum +12.30%
Coin of the day
SAFEcoin SAFEcoin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Pozycja w akcjach #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Cena akcji
$22.26
Ostatnia synchronizacja: 2024-03-22
Kapitalizacja rynkowa
$553.40M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Graphite Bio, Inc. (GRPH)

Kategoria

Healthcare
Historia ceny akcji dla Graphite Bio, Inc. (GRPH)
Najwyższa cena zamknięcia: $23.07 dnia 2024-03-01

Najniższa cena zamknięcia: $174.18 dnia 2021-06-01
Historia cen akcji firmy Graphite Bio, Inc. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 40.75%
2023 -26.18%
2022 -70.69%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $754.06 6.46%
CH